Phase II Trial of Abraxane in the Treatment of Patients With Pancreatic Cancer Who Have Failed First-Line Treatment With Gemcitabine-Based Therapy.
Phase of Trial: Phase II
Latest Information Update: 17 May 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 May 2010 Results will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).